Avanos Medical, Inc. (AVNS)
24.99
-0.04
(-0.16%)
USD |
NYSE |
Jun 10, 16:00
24.99
0.00 (0.00%)
After-Hours: 16:41
Avanos Medical Enterprise Value : 1.241B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 1.241B |
| June 08, 2026 | 1.240B |
| June 05, 2026 | 1.242B |
| June 04, 2026 | 1.240B |
| June 03, 2026 | 1.239B |
| June 02, 2026 | 1.239B |
| June 01, 2026 | 1.242B |
| May 29, 2026 | 1.230B |
| May 28, 2026 | 1.228B |
| May 27, 2026 | 1.230B |
| May 26, 2026 | 1.228B |
| May 22, 2026 | 1.221B |
| May 21, 2026 | 1.226B |
| May 20, 2026 | 1.227B |
| May 19, 2026 | 1.228B |
| May 18, 2026 | 1.227B |
| May 15, 2026 | 1.226B |
| May 14, 2026 | 1.226B |
| May 13, 2026 | 1.227B |
| May 12, 2026 | 1.227B |
| May 11, 2026 | 1.231B |
| May 08, 2026 | 1.230B |
| May 07, 2026 | 1.229B |
| May 06, 2026 | 1.227B |
| May 05, 2026 | 1.226B |
| Date | Value |
|---|---|
| May 04, 2026 | 1.224B |
| May 01, 2026 | 1.224B |
| April 30, 2026 | 1.222B |
| April 29, 2026 | 1.223B |
| April 28, 2026 | 1.222B |
| April 27, 2026 | 1.222B |
| April 24, 2026 | 1.224B |
| April 23, 2026 | 1.226B |
| April 22, 2026 | 1.223B |
| April 21, 2026 | 1.223B |
| April 20, 2026 | 1.223B |
| April 17, 2026 | 1.222B |
| April 16, 2026 | 1.224B |
| April 15, 2026 | 1.227B |
| April 14, 2026 | 1.222B |
| April 13, 2026 | 750.96M |
| April 10, 2026 | 734.62M |
| April 09, 2026 | 730.42M |
| April 08, 2026 | 722.49M |
| April 07, 2026 | 711.75M |
| April 06, 2026 | 718.29M |
| April 02, 2026 | 723.89M |
| April 01, 2026 | 730.42M |
| March 31, 2026 | 726.69M |
| March 30, 2026 | 677.15M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 82.51B |
| Embecta Corp. | 1.375B |
| Abbott Laboratories | 186.33B |
| AngioDynamics, Inc. | 487.94M |
| Alphatec Holdings, Inc. | 1.742B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.10M |
| Revenue (Quarterly) | 182.20M |
| Total Expenses (Quarterly) | 177.10M |
| EPS Diluted (Quarterly) | 0.1074 |
| Gross Profit Margin (Quarterly) | 48.52% |
| Profit Margin (Quarterly) | 2.80% |
| Earnings Yield | -6.44% |
| Operating Earnings Yield | 2.99% |
| Normalized Earnings Yield | -0.7447 |